Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Japanese Journal of Complementary and Alternative Medicine ; : 17-22, 2017.
Artigo em Japonês | WPRIM | ID: wpr-378869

RESUMO

To evaluate the impact of coenzyme Q10 (CoQ10) intake on body odor, two studies that focused on 2-nonenal contained in the gases emanated from the skin were conducted. The first study targeted 20 healthy women aged 65–74 years in a placebo-controlled cross-comparison study. Subjects were divided into two groups using blood CoQ10 concentration as an index, with ubiquinol (QH) or placebos administered every 4 weeks (5-week washout). On measuring concentrations of CoQ10 in blood and 2-nonenal in skin gas before and after continuous use, CoQ10 level of QH intake group increased significantly, whereas 2-nonenal level reduced significantly. In the second study, 24 healthy women aged 65–74 years were divided into four groups. QH, ubiquinone, vitamin E and placebos were administered in 4 weeks, and each concentrations of 2-nonenal in skin gas were measured. QH and ubiquinone reduced 2-nonenal in skin gas; however, changes in vitamin E were not observed. Therefore, CoQ10 intake reduced 2-nonenal emanation from the body.

2.
Arq. bras. endocrinol. metab ; 52(8): 1345-1349, Nov. 2008. ilus
Artigo em Inglês | LILACS | ID: lil-503303

RESUMO

Maternally inherited diabetes and deafness (MIDD) has been related to an A to G transition in the mitochondrial tRNA Leu (UUR) gene at the base pair 3243. This subtype of diabetes is characterized by maternal transmission, young age at onset and bilateral hearing impairment. Besides diabetes and deafness, the main diagnostic features, a wide range of multisystemic symptoms may be associated with the A3243G mutation. Organs that are most metabolically active, such as muscles, myocardium, retina, cochlea, kidney and brain are frequently affected. Gastrointestinal tract symptoms are also common in patients with mitochondrial disease and constipation and diarrhea are the most frequent manifestations. However, there are few prior reports of intestinal pseudo obstruction in MIDD patients. Here we report the case of a patient with MIDD associated with the mtDNA A3243G mutation who developed chronic intestinal pseudo obstruction, and the introduction of Coenzyme Q10 as adjunctive therapy led to a solution of the pseudo obstruction.


Diabetes mitocondrial ou diabetes e surdez de herança maternal (MIDD, acrônimo de maternally inherited diabetes and deafness) é freqüentemente associado à mutação mitocondrial A3243G. Esse subtipo de diabetes é caracterizado por transmissão materna, disacusia neuro-sensorial bilateral e idade precoce de aparecimento. Além do diabetes e da surdez, principais características diagnósticas, outros sintomas em diferentes órgãos podem também associar-se à mutação A3243G. Os órgãos que são metabolicamente mais ativos, tais como músculos, miocárdio, retina, cóclea, rim e cérebro, são freqüentemente afetados. Sintomas do trato gastrintestinal também são comuns em pacientes com doença mitocondrial, sendo diarréia e obstipação as manifestações mais freqüentes. Entretanto, há poucos relatos de pseudo-obstrução intestinal em portadores de diabetes mitocondrial. Este relato descreve o caso de uma paciente com diabetes mitocondrial que apresentou pseudo-obstrução intestinal e que com a introdução de coenzima Q10, como terapia adjunta, teve resolução o quadro.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Complicações do Diabetes , Diabetes Mellitus , Surdez/complicações , Pseudo-Obstrução Intestinal , Ubiquinona/análogos & derivados , Vitaminas/uso terapêutico , DNA Mitocondrial/genética , Surdez/genética , Diabetes Mellitus/genética , Pseudo-Obstrução Intestinal/tratamento farmacológico , Pseudo-Obstrução Intestinal/genética , Linhagem , Mutação Puntual/genética , Ubiquinona/uso terapêutico
3.
Japanese Journal of Physical Fitness and Sports Medicine ; : S247-S250, 2006.
Artigo em Inglês | WPRIM | ID: wpr-379129

RESUMO

A double-blind placebo-controlled trial was undertaken to evaluate the synergic effects of coenzymeQ10 (CoQ10) and creatine (Cr) through oral supplementation on the intermittent short duration high-intensity exercise on a cycle ergometer. Twenty-eight male athletes were divided into four groups of CoQ10 and Cr (CoQ10+Cr), CoQ10 (CoQ10+Pl), Cr (Pl+Cr) and placebo group (Pl+Pl). Each participant was instructed to have 100 mg of CoQ10 and/or 5 g of Cr per day for 2 weeks. Repetitive 5 bouts of 10-sec high-intensity cycle exercise tests were performed before and after supplementations. After supplementations, subjects in (CoQ10+Cr) revealed most improved performance in mean power outputs at the 2<sup>nd</sup> (p<0.05), the 3<sup>rd</sup> (p<0.05), the 4<sup>th</sup> (p<0.05) and the 5<sup>th</sup> set (p=0.06), comparing with the participants in the other 3 groups. These findings suggest that enhanced mean power output on repetitive short duration high-intensity exercise can be acquired after supplementing CoQ10 combined with Cr.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA